Stephens Consulting’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Stephens Consulting's AMGN Position: Q4 2025 in Review
Stephens Consulting increased its Amgen (AMGN) stake by 0.74% in Q4 2025, buying an estimated $3.17K and bringing the position to 1,370 shares worth $448K. The position accounts for 0.14% of the portfolio, ranked #38.
Stephens Consulting first reported a position in AMGN in Q4 2021 and has held it in 17 quarters since. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Stephens Consulting held 1,370 shares of Amgen worth $448K as of Q4 2025.
- Stephens Consulting bought 10 Amgen shares in Q4 2025, an estimated $3.17K.
- Amgen made up 0.14% of Stephens Consulting's portfolio in Q4 2025, its #38 holding.
- Stephens Consulting first reported a position in Amgen in Q4 2021 and has held it in 17 quarters since.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.